Dazostinag sodium is under clinical development by Takeda Pharmaceutical and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

Nasal hair may seem like a grooming nuisance, but it plays a critical role in respiratory health. Improper removal methods ...

People with allergies or asthma have more diverse fungal communities thriving in their noses, according to new research.

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

A young man, who had been experiencing persistent sneezing and a runny nose, was shocked to discover that a dice had been lodged in his nasal cavity for more than 20 years. The revelation has also ...

A recent study has shed light on the nasal mycobiome’s potential influence in chronic respiratory diseases. Learn more.

Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Paranasal Sinus And Nasal Cavity Cancer.

GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...

Polyrizon’s innovative Capture and Contain (C&C™) platform utilizes a natural 3D polymeric network engineered to adhere optimally to the nasal mucosa. This advanced network forms a physical barrier ...